Novel <i>Emblica officinalis</i> extract containing β-glucogallin <i>vs.</i> metformin: a randomized, open-label, comparative efficacy study in newly diagnosed type 2 diabetes mellitus patients with dyslipidemia
Muhammed Majeed, Lakshmi Mundkur, Shaji Paulose, Kalyanam Nagabhushanam
Abstract
Comparative clinical trial shows higher efficacy of EOE containing β-glucogallin over metformin in newly diagnosed T2DM patients with dyslipidemia.
Topics & Concepts
MetforminDyslipidemiaEmblica officinalisMedicineType 2 Diabetes MellitusRandomized controlled trialDiabetes mellitusType 2 diabetesPharmacologyInternal medicineOpen labelTraditional medicineEndocrinologyGinkgo biloba and Cashew ApplicationsNatural Antidiabetic Agents StudiesPhytochemicals and Antioxidant Activities